Christopher B. Fox

Development and Characterization of Synthetic Glucopyranosyl Lipid Adjuvant System as a Vaccine Adjuvant

Rhea N. Coler, Sylvie Bertholet, Magdalini Moutaftsi et al. · PLoS ONE · 2011 · 310 citations · Full text

Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses

Kevin O. Saunders, Esther Lee, Robert Parks et al. · Nature · 2021 · 269 citations · Full text

Vaccination, Antibody Vaccine, Vaccine Development +5

Different human vaccine adjuvants promote distinct antigen-independent immunological signatures tailored to different pathogens

Niels Peter Hell Knudsen, Anja Weinreich Olsen, Cecilia Buonsanti et al. · Scientific Reports · 2016 · 229 citations · Full text

A Nanostructured Lipid Carrier for Delivery of a Replicating Viral RNA Provides Single, Low-Dose Protection against Zika

Jesse H. Erasmus, Amit P. Khandhar, Jeff Guderian et al. · Molecular Therapy · 2018 · 166 citations · Full text

3M-052, a synthetic TLR-7/8 agonist, induces durable HIV-1 envelope–specific plasma cells and humoral immunity in nonhuman primates

Sudhir Pai Kasturi, Mohammed Ata Ur Rasheed, Colin Havenar‐Daughton et al. · Science Immunology · 2020 · 143 citations · Full text

Immunology, Immunodominance, Immunotherapeutics +21